Feel like yourself again
Sustained energy for the moments that matter most.
Free online eligibility check — early access, by invitation
Real GLP-1 results.
Starting at $149.99 per 28-day supply. No insurance needed. Prescribed when medically appropriate and delivered to your door.
Free eligibility check. No charge if you don't qualify.
Online health intakeLicensed-provider reviewMedication dispensed by a licensed US pharmacyTransparent starting pricesDiscreet home deliveryOngoing clinical supportOnline health intakeLicensed-provider reviewMedication dispensed by a licensed US pharmacyTransparent starting pricesDiscreet home deliveryOngoing clinical supportOnline health intakeLicensed-provider reviewMedication dispensed by a licensed US pharmacyTransparent starting pricesDiscreet home deliveryOngoing clinical supportOnline health intakeLicensed-provider reviewMedication dispensed by a licensed US pharmacyTransparent starting pricesDiscreet home deliveryOngoing clinical support
Three steps to a healthier you.
Step 01
Complete your intake
Fill out your health history online in about 5 minutes. No awkward waiting rooms. Your health information is submitted through a private online intake.
Step 02
Clinical review
A licensed provider reviews your health history, evaluates your eligibility, and determines whether an available treatment option may be medically appropriate for you.
Step 03
Receive your medication
Your medication is dispensed by a licensed US pharmacy and shipped discreetly to your door — with ongoing support.
Personalized GLP-1 treatment options starting at $149.99 per 28-day supply.
Your licensed provider will determine which available treatment option may be medically appropriate for you.
COMPOUNDEDGLP-1 + GIP
Tirzepatide
A clinician-prescribed treatment option that may support appetite regulation and weight management as part of a medically supervised plan. Individual results vary.
Starting at$249.99/28-day supply
COMPOUNDEDGLP-1
Semaglutide
A clinician-prescribed GLP-1 treatment option that may support appetite regulation and weight management as part of a medically supervised plan. Individual results vary.
Starting at$149.99/28-day supply
BRAND-NAMEGLP-1FDA-APPROVED
Foundayo™ Tablets
Foundayo™ (orforglipron) is a once-daily oral GLP-1 medication FDA-approved, together with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in eligible adults.
Starting at$199.99/month
BRAND-NAMEGLP-1FDA-APPROVED
Wegovy® Tablets
Wegovy® tablets are a once-daily oral semaglutide treatment FDA-approved, together with a reduced-calorie diet and increased physical activity, for chronic weight management in eligible adults.
Starting at$249.99/month
BRAND-NAMEGLP-1 + GIPFDA-APPROVED
Zepbound®
Zepbound® (tirzepatide) is a once-weekly injection FDA-approved, together with a reduced-calorie diet and increased physical activity, for chronic weight management in eligible adults and for moderate-to-severe obstructive sleep apnea in adults with obesity.
Starting at$449.99/month
BRAND-NAMEGLP-1FDA-APPROVED
Wegovy® Pens
Wegovy® is a once-weekly semaglutide injection FDA-approved for chronic weight management in eligible adults. It is also approved to reduce the risk of major cardiovascular events in certain adults with cardiovascular disease and overweight or obesity.
Starting at$349.99/month
BRAND-NAMEGLP-1
Ozempic®
Ozempic® (semaglutide) is a once-weekly injection FDA-approved for adults with type 2 diabetes. It is not FDA-approved for chronic weight management.
Starting at$349.99/month
BRAND-NAMEGLP-1 + GIP
Mounjaro®
Mounjaro® (tirzepatide) is a once-weekly injection FDA-approved for adults with type 2 diabetes. It is not FDA-approved for chronic weight management.
Starting at$1,249.99/month
Weight loss is about more than willpower.
For many people, biology makes losing weight—and keeping it off—far more difficult. GLP-1 medications can help regulate appetite, improve satiety, and reduce food intake as part of a medically supervised weight-management plan.
Body weight support (Tirzepatide)
GLP-1 + GIP
Tirzepatide acts on GLP-1 and GIP pathways involved in appetite and metabolic regulation. A licensed provider will determine whether it may be appropriate for you. Individual results vary.
Body weight support (Semaglutide)
GLP-1
Semaglutide acts on the GLP-1 pathway involved in appetite regulation and satiety. A licensed provider will determine whether it may be appropriate for you. Individual results vary.
What could 41 fewer pounds change for you?
More confidence in your clothes. More energy for the people and moments that matter. A lighter version of everyday life.
Your current weight (lbs):
270
Your starting point
270 lbs
Weight at 15% lower
229 lbs
Imagine what carrying 41 fewer pounds could mean for your confidence, energy, and everyday movement.
Check my eligibility — free
Free eligibility check. Takes about 5 minutes. No charge if you don’t qualify.
This calculator is an educational example based on the approximately 15% mean weight reduction observed over 68 weeks in the STEP 1 clinical trial of semaglutide 2.4 mg used with lifestyle intervention. It is not a prediction of your personal results, does not represent tirzepatide trial results, and does not establish the safety, effectiveness, or quality of compounded semaglutide. Individual results vary.
Eligibility
Who may qualify for prescription weight loss treatment?
Adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, may be candidates for certain prescription weight-management medications. Meeting these general criteria does not guarantee eligibility.
Eligibility depends on the specific medication, your medical history, current medications, treatment goals, and other clinical factors. Certain treatments may not be appropriate during pregnancy or breastfeeding, or for people with particular medical conditions or risk factors.
A licensed provider will review your complete health history and determine whether any available treatment option is medically appropriate for you. If you do not qualify, you will not be charged.
Compare
Semaglutide vs Tirzepatide — which is right for me?
Semaglutide and tirzepatide act through different hormone pathways. In clinical trials of FDA-approved brand-name products, tirzepatide produced greater average weight loss, while semaglutide has a longer real-world track record and a lower starting cost. These trial results do not establish the safety, efficacy, or quality of compounded formulations.
GLP-1
Semaglutide
GLP-1 receptor agonist
Average weight loss in brand-name clinical trials
Wegovy®: approximately 15% over 68 weeks in STEP 1
Dosing schedule
Once weekly injection
Compounded starting price
$149.99per 28-day supply
FDA-approved products containing the ingredient
Wegovy® — weight management; Ozempic® — type 2 diabetes
Common side effects
Nausea, constipation, fatigue
GLP-1 + GIP
Tirzepatide
Dual GLP-1 + GIP receptor agonist
Average weight loss in brand-name clinical trials
Zepbound®: approximately 20–22% over 72 weeks in SURMOUNT-1
Dosing schedule
Once weekly injection
Compounded starting price
$249.99per 28-day supply
FDA-approved products containing the ingredient
Zepbound® — weight management; Mounjaro® — type 2 diabetes
Common side effects
Nausea, diarrhea, decreased appetite
Compounded vs Brand-name
Different treatment options. Different regulatory pathways.
COMPOUNDED
Prepared by a compounding pharmacy
Tirzepatide, Semaglutide
- Regulation: Prepared by licensed US compounding pharmacies.
- Cost: $149.99–$249.99 per 28-day supply, out of pocket. No insurance required.
- Customization: Prepared in prescribed strengths and dispensed in a vial-and-syringe format.
- Supply: Availability varies and is confirmed at the time of prescribing.
BRAND-NAME
FDA-approved brand-name medications
Wegovy®, Zepbound®, Foundayo™, Ozempic®, Mounjaro®
- Regulation: FDA-approved and manufactured by Novo Nordisk or Eli Lilly.
- Cost: From $199.99 per month. Insurance and savings cards may apply.
- Available formats: Product-specific oral tablets or pre-filled injection pens.
- Supply: Subject to manufacturer shortages from time to time.
A licensed provider will determine whether a compounded or FDA-approved treatment option may be medically appropriate based on your individual needs and product availability.
Compounded medications are not FDA-approved for safety, efficacy, or quality.
Safety first
Important safety considerations
Prescription GLP-1 and GIP/GLP-1 medications are not appropriate for everyone. Safety and eligibility depend on the specific medication, your medical history, current medications, and other clinical factors. Tell your licensed provider if any of the following apply to you:
- You or a family member have had medullary thyroid carcinoma, or you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- You have had a serious allergic reaction to semaglutide, tirzepatide, or any ingredient in a prescribed medication.
- You are pregnant, breastfeeding, planning a pregnancy, or become pregnant during treatment.
- You have a history of pancreatitis, gallbladder problems, severe gastroparesis, or another serious digestive condition.
- You have type 1 diabetes, a history of diabetic ketoacidosis, diabetic retinopathy, kidney problems, or take insulin or certain other diabetes medications.
- You have an upcoming surgery or procedure involving general anesthesia or deep sedation.
- Age eligibility varies by medication and program availability.
This is not a complete list of risks, warnings, or reasons a medication may be inappropriate. Complete the private online intake so a licensed provider can review your health history and determine whether an available treatment option may be medically appropriate. Do not start, stop, or change a prescription medication without guidance from a qualified healthcare professional.
Common questions. Honest answers.
Coverage varies by plan, medication, and individual eligibility. Some services or prescription expenses may qualify for HSA or FSA reimbursement depending on your plan. Check with your insurer or plan administrator before purchase.
Response and timing vary by medication, dose, adherence, and individual factors. Some people notice changes during dose escalation, while others take longer. Your licensed provider will discuss realistic expectations based on your treatment plan. Results are not guaranteed.
Common side effects vary by medication and may include nausea, vomiting, diarrhea, constipation, abdominal discomfort, and decreased appetite. Serious reactions can also occur, including pancreatitis, gallbladder problems, dehydration-related kidney injury, severe gastrointestinal reactions, low blood sugar when combined with certain diabetes medications, and serious allergic reactions. Review the medication guide and discuss your complete health history with your licensed provider.
Care is generally provided online where available. A licensed provider may determine that laboratory testing, additional evaluation, or in-person medical care is needed before or during treatment.
If an available treatment option is not medically appropriate for you, a licensed provider will explain the decision and may recommend that you discuss other options with your regular healthcare professional. You will not be charged for the eligibility check.
We focus on GLP-1 weight-management care. Your licensed provider remains involved beyond signup, with ongoing clinical support where available.
Ready to see if GLP-1 is right for you? ChubbyNoMore is with you every step.
- Clinician reviewed
- Private online intake
- Delivered to your door
- Availability varies by state